Worth reading
45Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
425
¥ millionWording
Conditional
How definitive the wording is.Details of issuance or disposal
第三者割当による第２回新株予約権（行使価額修正条項付）の発行
Specific use of funds
ソフトウェア受託開発に係る研究開発資金Amount ¥210 million / Scheduled timing of expenditures 2021年4月～2023年3月
自社ブランド商材に係る研究開発資金（ＧＡＫＵＥＮ、ＪＭＩＣＳ、ＢａｎｋＮｅｏ等）Amount ¥550 million / Scheduled timing of expenditures 2021年4月～2023年3月
Working capitalAmount ¥425 million / Scheduled timing of expenditures April 2021 to March 2026
Terms of the stock acquisition rights
Exercise price
行使価額修正条項付であることのみ記載。具体的な当初行使価額・修正下限はNot disclosed
Most recent equity financing
Timing 2021年3月5日付開示 / Type 第三者割当による第2回新株予約権（行使価額修正条項付）の発行 / Amount Not disclosed
Impact on Business Performance
本件変更が2026年3月期の当社連結業績に与える影響は軽微と考えております。今後の業績に与える影響について開示すべき事項が生じた場合には、速やかにお知らせいたします。
| Item | Details |
|---|---|
| Type of issuance or disposal | 第三者割当による第２回新株予約権（行使価額修正条項付）の発行 |
| Specific use of funds | Details ソフトウェア受託開発に係る研究開発資金 / Amount ¥210 million / Scheduled timing of expenditures 2021年4月～2023年3月, Details 自社ブランド商材に係る研究開発資金（ＧＡＫＵＥＮ、ＪＭＩＣＳ、ＢａｎｋＮｅｏ等） / Amount ¥550 million / Scheduled timing of expenditures 2021年4月～2023年3月, Details Working capital / Amount ¥425 million / Scheduled timing of expenditures April 2021 to March 2026 |
| Exercise price | 行使価額修正条項付であることのみ記載。具体的な当初行使価額・修正下限はNot disclosed |
| Most recent equity financing | Timing 2021年3月5日付開示 / Type 第三者割当による第2回新株予約権（行使価額修正条項付）の発行 / Amount Not disclosed |
| Impact on Business Performance | 本件変更が2026年3月期の当社連結業績に与える影響は軽微と考えております。今後の業績に与える影響について開示すべき事項が生じた場合には、速やかにお知らせいたします。 |
Items this document does not state (23)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesPayment dateIntended allotteeIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.新型コロナウイルス感染症の影響でM&A等の活動が停滞したことに加え、拙速なM&Aを避け、投資効率・資本収益性を重視する方針へ転換し、投資優先順位を整理したため。当面の事業運営の安定性を確保する観点から、対象資金を運転資金に充当する。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.